These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11701496)

  • 1. Engineering design of optimal strategies for blood clot dissolution.
    Diamond SL
    Annu Rev Biomed Eng; 1999; 1():427-62. PubMed ID: 11701496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.
    Anand S; Kudallur V; Pitman EB; Diamond SL
    Ann Biomed Eng; 1997; 25(6):964-74. PubMed ID: 9395042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport processes in fibrinolysis and fibrinolytic therapy.
    Blinc A; Francis CW
    Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow through clots determines the rate and pattern of fibrinolysis.
    Blinc A; Kennedy SD; Bryant RG; Marder VJ; Francis CW
    Thromb Haemost; 1994 Feb; 71(2):230-5. PubMed ID: 8191404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin clot properties and their modulation in thrombotic disorders.
    Undas A
    Thromb Haemost; 2014 Jul; 112(1):32-42. PubMed ID: 24671700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model for the dissolution of non-occlusive blood clots in fast tangential blood flow.
    Sersa I; Tratar G; Mikac U; Blinc A
    Biorheology; 2007; 44(1):1-16. PubMed ID: 17502685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.
    Murciano JC; Medinilla S; Eslin D; Atochina E; Cines DB; Muzykantov VR
    Nat Biotechnol; 2003 Aug; 21(8):891-6. PubMed ID: 12845330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of blood clot degradation fragment sizes in relation to plasma flow velocity.
    Bajd F; Vidmar J; Blinc A; Serša I
    Gen Physiol Biophys; 2012 Sep; 31(3):237-45. PubMed ID: 23047936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
    Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
    Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow.
    Piebalgs A; Xu XY
    J R Soc Interface; 2015 Dec; 12(113):20150949. PubMed ID: 26655469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XI and protection of the fibrin clot against lysis--a role for the intrinsic pathway of coagulation in fibrinolysis.
    Bouma BN; von dem Borne PA; Meijers JC
    Thromb Haemost; 1998 Jul; 80(1):24-7. PubMed ID: 9684779
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of flow on lysis of plasma clots in a plasma environment.
    Sakharov DV; Rijken DC
    Thromb Haemost; 2000 Mar; 83(3):469-74. PubMed ID: 10744155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood clots are rapidly assembled hemodynamic sensors: flow arrest triggers intraluminal thrombus contraction.
    Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2938-45. PubMed ID: 23087356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.